D
Dyne Therapeutics, Inc. (DYN)
NMS – Real Time Price. Currency in USD
20.94
+0.33 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
20.94
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
20.94
+0.33 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
20.94
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $753.1M significantly exceed its total debt $174.9M, ensuring strong financial flexibility
Total current assets $1.0B exceed Total current liabilities $51.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-29.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$145.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 19.92 | 6.05 | 10 | |
| Quick ratio | 19.92 | 5.63 | 10 | |
| Debt to Equity | 0.20 | 0.30 | 9.0 | |
| Debt to Assets | 0.16 | 1.04 | 8.0 | |
| Interest coverage | -29.81 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -3M | -2M | -2M | -2M | -2M |
| Operating Income | -171M | -242M | -344M | -468M | -471M |
| Net Income | -168M | -236M | -317M | -446M | -452M |
| EBITDA | -168M | -240M | -342M | -466M | -469M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 22.47 | 5.5 |
| Next quarter | N/A | -0.75 | 1.0 |
| Current year | N/A | 10.97 | 4.0 |
| Next year | N/A | 4.33 | 2.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -7.94 | 3.95 | -29.22 | 4.0 |
| Y/Y | 999 | -4.75 | 30.48 | -35.8 | 5.5 |
| 3y average | 999 | -38.47 | -3.51 | -40.11 | 3.3 |
| 5y average | 999 | -55.83 | 1.65 | -61.19 | 3.8 |
| Weighted average score | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |